我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的隐私政策。
未知生产厂商 • For routine prophylaxis of bleeding in patients with congenital factor XIII A-Subunit deficiency.
Catridecacog is a recombinant FXIII subunit‐A molecule evaluated for clotting factor replacement therapy in congenital FXIII deficiency.
